Table 1.
End-stage CKD | |||
---|---|---|---|
|
proET-1 <250 pMol/L (n = 11) mean ± SD |
proET-1 >250 pMol/L (n = 9) mean (SD) |
statistical significance |
proET-1 (pMol/L) |
210 ± 18 |
285 ± 40 |
p = 0.000 |
PLTs with <25% granules staining density (%) |
33 ± 13 |
46 ± 8 |
p = 0.008 |
PLTs with >75% granules staining density (%) |
34 ± 15 |
18 ± 10 |
p = 0.001 |
TAT (μg/L) |
3.8 ± 1.0 |
3.8 ± 1.4 |
NS |
Fibrinogen (g/L) | 4.1 ± 1.3 | 3.9 ± 1.2 | NS |
Evaluation of proET-1, PLT granule staining density, TAT and fibrinogen (mean value with standard deviation) established in the group with end-stage CKD. Results of statistically significant evaluation are indicated as p-values.
NS = deviation not statistically significant.